• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
An Elusive Case of Mycosis Fungoides: Case Report and Review of the Literature.蕈样肉芽肿一例:病例报告及文献复习。
J Gen Intern Med. 2019 Nov;34(11):2669-2674. doi: 10.1007/s11606-019-05231-z. Epub 2019 Aug 6.
2
Response to brentuximab vedotin versus physician's choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis.对 Brentuximab vedotin 与医师选择的回应:根据 CD30 表达和大细胞转化状态在蕈样肉芽肿患者中的比较:ALCANZA 子分析。
Eur J Cancer. 2021 May;148:411-421. doi: 10.1016/j.ejca.2021.01.054. Epub 2021 Mar 29.
3
Poikilodermatous mycosis fungoides with CD30-positive large cell transformation successfully treated by brentuximab vedotin.蕈样肉芽肿病伴 CD30 阳性大细胞转化经 Brentuximab vedotin 治疗后成功缓解。
Dermatol Ther. 2020 Jan;33(1):e13152. doi: 10.1111/dth.13152. Epub 2019 Nov 19.
4
RF - Brentuximab as Treatment for CD30 Primary Cutaneous Lymphoma.利妥昔单抗 - 本妥昔单抗治疗CD30原发性皮肤淋巴瘤
Actas Dermosifiliogr (Engl Ed). 2019 Nov;110(9):769-770. doi: 10.1016/j.ad.2018.03.025. Epub 2019 May 28.
5
Phase I/II clinical trial of brentuximab vedotin for pretreated Japanese patients with CD30-positive cutaneous T-cell lymphoma.本妥昔单抗治疗经治的日本CD30阳性皮肤T细胞淋巴瘤患者的I/II期临床试验。
J Dermatol. 2024 Aug;51(8):1037-1049. doi: 10.1111/1346-8138.17324. Epub 2024 Jun 14.
6
A Case Series on the Use of Brentuximab Vedotin for the Treatment of Mycosis Fungoides.布仑妥昔单抗贝妥昔单抗治疗蕈样肉芽肿的病例系列研究
J Drugs Dermatol. 2023 Dec 1;22(12):e33-e34. doi: 10.36849/JDD.6981.
7
Treatment of mycosis fungoides with brentuximab vedotin: Assessing CD30 expression by immunohistochemistry and quantitative real-time polymerase chain reaction.用维布妥昔单抗治疗蕈样肉芽肿:通过免疫组织化学和定量实时聚合酶链反应评估CD30表达
J Cutan Pathol. 2022 Mar;49(3):314-317. doi: 10.1111/cup.14178. Epub 2021 Dec 22.
8
Brentuximab vedotin in CD30 primary cutaneous T-cell lymphomas: a review and analysis of existing data.本妥昔单抗维特辛治疗 CD30 阳性原发性皮肤 T 细胞淋巴瘤:现有数据的回顾和分析。
Int J Dermatol. 2017 Dec;56(12):1400-1405. doi: 10.1111/ijd.13696. Epub 2017 Aug 1.
9
Impressive response of CD30-negative, treatment-refractory mycosis fungoides to brentuximab vedotin.CD30 阴性、治疗抵抗的蕈样肉芽肿对 Brentuximab vedotin 治疗的显著反应。
Dermatol Ther. 2019 Mar;32(2):e12835. doi: 10.1111/dth.12835. Epub 2019 Feb 17.
10
Existing and Emerging Therapies for Cutaneous T-Cell Lymphoma.现有的和新兴的皮肤 T 细胞淋巴瘤治疗方法。
J Cutan Med Surg. 2019 May/Jun;23(3):319-327. doi: 10.1177/1203475419840629. Epub 2019 Apr 3.

引用本文的文献

1
Subcutaneous Panniculitis-like T-Cell Lymphoma: Diagnostic Challenge and Successful Multimodal Management with Integra Dermal Matrix-Case Report and Review of the Literature.皮下脂膜炎样T细胞淋巴瘤:诊断挑战与使用Integra真皮基质的成功多模式治疗——病例报告及文献复习
Diseases. 2025 Jun 30;13(7):201. doi: 10.3390/diseases13070201.
2
Hypopigmented Mycosis Fungoides in an 11-Year-Old Palestinian Boy.一名11岁巴勒斯坦男孩的色素减退型蕈样肉芽肿
Case Rep Dermatol Med. 2023 Feb 16;2023:4310796. doi: 10.1155/2023/4310796. eCollection 2023.

本文引用的文献

1
Nail psoriasis: clinical features, pathogenesis, differential diagnoses, and management.甲银屑病:临床特征、发病机制、鉴别诊断及治疗
Psoriasis (Auckl). 2017 Oct 16;7:51-63. doi: 10.2147/PTT.S126281. eCollection 2017.
2
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial.本妥昔单抗维达妥或医师选择治疗 CD30 阳性皮肤 T 细胞淋巴瘤(ALCANZA):一项国际性、开放性标签、随机、3 期、多中心试验。
Lancet. 2017 Aug 5;390(10094):555-566. doi: 10.1016/S0140-6736(17)31266-7. Epub 2017 Jun 7.
3
Early malignant syphilis.早期恶性梅毒
An Bras Dermatol. 2016 Sep-Oct;91(5 suppl 1):148-150. doi: 10.1590/abd1806-4841.20164491.
4
Human immunodeficiency virus-positive secondary syphilis mimicking cutaneous T-cell lymphoma.模仿皮肤T细胞淋巴瘤的人类免疫缺陷病毒阳性二期梅毒
Diagn Pathol. 2015 Oct 8;10:185. doi: 10.1186/s13000-015-0419-5.
5
Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.原发性皮肤淋巴瘤:ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2013 Oct;24 Suppl 6:vi149-54. doi: 10.1093/annonc/mdt242. Epub 2013 Jul 17.
6
Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases.蕈样肉芽肿转化的预后因素:100 例回顾性分析。
Blood. 2012 Feb 16;119(7):1643-9. doi: 10.1182/blood-2011-08-376319. Epub 2011 Dec 12.
7
Regulatory T cells and immunodeficiency in mycosis fungoides and Sézary syndrome.调节性 T 细胞与蕈样肉芽肿和赛泽里综合征中的免疫缺陷。
Leukemia. 2012 Mar;26(3):424-32. doi: 10.1038/leu.2011.237. Epub 2011 Sep 9.
8
Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformation.晚期皮肤T细胞淋巴瘤和大细胞转化患者的长期预后
Blood. 2008 Oct 15;112(8):3082-7. doi: 10.1182/blood-2008-05-154609. Epub 2008 Jul 22.
9
Acquired palmoplantar keratoderma.获得性掌跖角化病。
Am J Clin Dermatol. 2007;8(1):1-11. doi: 10.2165/00128071-200708010-00001.
10
Cutaneous T-cell lymphoma with HTLV-I infection: clinical overlap with adult T-cell leukemia/lymphoma.伴有人类嗜T淋巴细胞病毒I型(HTLV-I)感染的皮肤T细胞淋巴瘤:与成人T细胞白血病/淋巴瘤的临床重叠
Int J Dermatol. 2006 Apr;45(4):447-9. doi: 10.1111/j.1365-4632.2006.02687.x.

蕈样肉芽肿一例:病例报告及文献复习。

An Elusive Case of Mycosis Fungoides: Case Report and Review of the Literature.

机构信息

Department of Medicine, Johns Hopkins University School of Medicine, 600 N. Wolfe Street, Baltimore, MD, 21287, USA.

Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

出版信息

J Gen Intern Med. 2019 Nov;34(11):2669-2674. doi: 10.1007/s11606-019-05231-z. Epub 2019 Aug 6.

DOI:10.1007/s11606-019-05231-z
PMID:31388911
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6848709/
Abstract

Erythroderma refers to a spectrum of skin diseases resulting in diffuse erythema and scaling encompassing ≥ 90% of the body surface area. The differential diagnosis ranges from primary dermatologic diseases such as atopic dermatitis and psoriasis to potentially deadly causes such as staphylococcal toxic shock syndrome, toxic epidermal necrolysis, and malignancy. Cutaneous T cell lymphoma (CTCL) is an uncommon but highly morbid cause of erythroderma. This non-Hodgkin lymphoma remains a diagnostic challenge due to its variable clinical presentation and varied histologic features. Mycosis fungoides (MF) is the most common form of CTCL. Making a timely diagnosis is challenging as it may mimic inflammatory diseases of the skin including eczema, psoriasis, lichen planus, and cutaneous lupus. We present a case of a 58-year-old man who presented with 5 years of cutaneous symptoms and several months of fevers and night sweats, ultimately diagnosed as MF. Owing to diffuse CD30 positivity, he was a candidate for brentuximab vedotin, an antibody-drug conjugate medication that selectively targets the CD30 antigen. This resulted in an excellent therapeutic response.

摘要

红皮病是指一系列导致皮肤弥漫性红斑和鳞屑的疾病,累及面积≥90%。鉴别诊断范围从特应性皮炎和银屑病等原发性皮肤病到葡萄球菌中毒性休克综合征、中毒性表皮坏死松解症和恶性肿瘤等潜在致命原因。皮肤 T 细胞淋巴瘤(CTCL)是一种罕见但高度致命的红皮病原因。由于其可变的临床表现和不同的组织学特征,这种非霍奇金淋巴瘤仍然是一个诊断挑战。蕈样肉芽肿(MF)是 CTCL 最常见的形式。及时做出诊断具有挑战性,因为它可能模仿包括湿疹、银屑病、扁平苔藓和皮肤狼疮在内的皮肤炎症性疾病。我们报告了一例 58 岁男性,他有 5 年的皮肤症状和几个月的发热和盗汗,最终被诊断为 MF。由于弥漫性 CD30 阳性,他是 Brentuximab vedotin 的候选者,Brentuximab vedotin 是一种抗体药物偶联药物,可选择性靶向 CD30 抗原。这导致了极好的治疗反应。